| TSHA Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the TSHA shares outstanding history going back to 9/24/2020:
Also see: TSHA Market Cap History TSHA YTD Return |
TSHA Shares Outstanding History — Taysha Gene Therapies Share Count Over Time
As of 5/6/2026 Taysha Gene Therapies has 287.36 million TSHA shares outstanding. Investors often track the TSHA shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows TSHA share count trends over time, with 24 historical shares outstanding datapoints presented, dating back to 9/24/2020.
| TSHA Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||
TSHA Historical Shares Outstanding: +45.84% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| TSHA Stock Price Chart |
| About Taysha Gene Therapies Inc |
| Taysha Gene Therapies Inc is a clinical-stage biotechnology company, which is focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system. Co.'s lead clinical program, TSHA-102, is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder. Co. is evaluating TSHA-102 in the REVEALPhase I/II adolescent and adult clinical trial, which is a first-in-human, open-label, randomized, dose escalation and dose-expansion, multicenter study evaluating the safety and preliminary efficacy of TSHA-102 in female patients aged 12-years and older with Rett syndrome. We show 24 historical shares outstanding datapoints in our coverage of TSHA's shares outstanding history. Understanding the changing numbers of TSHA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like TSHA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching TSHA by allowing them to research TSHA shares outstanding history as well as any other stock in our coverage universe. |
| TSHA Current Stock Quote |
Quotes delayed 20 minutes  Free TSHA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| TSHA Share Performance |
| Shares Outstanding Peers |
| Taysha Gene Therapies (TSHA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
TSRO Shares Outstanding History TSVT Shares Outstanding History TTNP Shares Outstanding History TTOO Shares Outstanding History TTPH Shares Outstanding History TVRD Shares Outstanding History TVTX Shares Outstanding History TVTY Shares Outstanding History TWST Shares Outstanding History TXAC Shares Outstanding History More Healthcare companies » |
TSHA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
